EyePoint Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2010 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.58 USD/shares, a 4.92% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.78 USD/shares, a 37.1% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.82 USD/shares, a 33.6% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -2.74 USD/shares, a 35% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -2.03 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$0.92 +33.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$3 -$1 -35% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$2 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2017 -$1 +$0.16 +23.5% Jul 1, 2016 Jun 30, 2017 10-K 2017-09-13
2016 -$1 -$1 -409% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-13
2015 $0.22 +$0.71 Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 $0 +$0.03 +5.77% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 -$1 +$0.67 +56.3% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 -$1 -$1 -170% Jul 1, 2011 Jun 30, 2012 10-K 2012-09-27
2011 $0 -$1 -192% Jul 1, 2010 Jun 30, 2011 10-K 2012-09-27
2010 $0.48 Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.